Literature DB >> 26258603

Strongyloides stercoralis infection in patients with systemic lupus erythematosus: diagnosis and prevention of severe strongyloidiasis.

Joelma Nascimento de Souza1, Elizabete De Jesus Inês1, Mittermayer Santiago2, Márcia Cristina Aquino Teixeira1, Neci Matos Soares1.   

Abstract

AIM: Strongyloides stercoralis infection is usually chronic and asymptomatic and may persist undiagnosed for decades. However, in immunocompromised individuals, the infection can cause hyperinfection and dissemination. Therefore, early diagnosis is essential to prevent severe forms of strongyloidiasis. The aims of this study were: (i) to evaluate the frequency of S. stercoralis infection in patients with systemic lupus erythematous (SLE) and (ii) to estimate specific immunoglobulins G (IgG) and E (IgE) production using an enzyme-linked immunosorbent assay (ELISA) method.
METHODS: Seventy-five SLE patients treated with prophylactic anthelmintic therapy were evaluated using the spontaneous sedimentation (SS), Baermann-Moraes (BM) and agar plate culture (APC) methods. Serum anti-S. stercoralis IgG and IgE antibodies were measured by ELISA.
RESULTS: Using parasitological methods, the frequency of intestinal parasites was 10.7%, whereas the frequency of S. stercoralis infection was 1.3%. The sensitivity of the ELISA to detect anti-S. stercoralis IgG and IgE was 80% and 76.9%, respectively. Both assays presented the same specificity of 96.7%. The frequency of anti-S. stercoralis IgG and IgE was 16% and 28%, respectively. Six patients were positive for both antibodies.
CONCLUSIONS: Diagnostic approaches using high-sensitivity parasitological methods and the detection of specific antibodies are essential for the diagnosis of strongyloidiasis in immunocompromised patients. Early detection of infection can alter the course of the disease via appropriate treatment, preventing the occurrence of severe strongyloidiasis.
© 2015 Asia Pacific League of Associations for Rheumatology and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  ELISA; Strongyloides; diagnosis; stercoralis; systemic lupus erythematosus

Mesh:

Substances:

Year:  2015        PMID: 26258603     DOI: 10.1111/1756-185X.12644

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  4 in total

Review 1.  Strongyloides stercoralis infection in a patient with rheumatoid arthritis and type 2 diabetes mellitus: a case-based review.

Authors:  Alireza Ashiri; Molouk Beiromvand; Abdollah Khanzadeh
Journal:  Clin Rheumatol       Date:  2019-05-23       Impact factor: 2.980

2.  Evaluation of Strongyloides stercoralis infection in patients with HTLV-1.

Authors:  Nilo Manoel Pereira Vieira Barreto; Marina Morena Brito Farias; Cíntia de Lima Oliveira; Weslei Almeida Costa Araujo; Maria Fernanda Rios Grassi; Joelma Nascimento de Souza; Beatriz Soares Jacobina; Márcia Cristina Aquino Teixeira; Bernardo Galvão-Castro; Neci Matos Soares
Journal:  Biomedica       Date:  2022-03-01       Impact factor: 1.173

3.  Ineffectiveness of TF-Test® and Coproplus® Methods in Strongyloides stercoralis Infection Diagnosis.

Authors:  Cíntia de Lima Oliveira; Joelma Nascimento de Souza; Alex Bruno da Silva Souza; Nilo Manoel Pereira Vieira Barreto; Irlana Dias Ribeiro; Larissa Mota Sampaio; Weslei Almeida Costa Araújo; Juliane Silva Batista Dos Santos; Márcia Cristina Aquino Teixeira; Neci Matos Soares
Journal:  Acta Parasitol       Date:  2022-01-20       Impact factor: 1.440

4.  Cardiac arrest in a case of systemic lupus erythematosus and hepatitis-B coinfection: Can Strongyloides stercoralis be the culprit?

Authors:  Kumar Saurabh; Vibhor Tak; Vijaya Lakshmi Nag; Gopal Krishna Bohra
Journal:  Trop Parasitol       Date:  2018-12-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.